Neoadjuvant Adebrelimab + DOS in Locally Advanced Resectable Gastric Cancer
Clinical trial NCT06475417 · UNKNOWN
Trial details
- NCT number
- NCT06475417
- Sponsor
- Tang-Du Hospital
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-05-24
- Primary completion
- 2025-05-20
- Enrollment
- 42
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.